In this issue we introduce our new IP podcast series "Meeting Room 7", in which we discuss patent and know-how licensing. Our first episode on "defining the deal" is available now.
In our recent articles, we consider the price that life sciences businesses can pay for an interim injunction and, separately, we look at the CMA's consumer protection investigation into a COVID-19 test provider.
Plus, the latest entry to our Life Sciences Legal A to Z considers the role of “valid claim” wording in patent licensing arrangements.
A link to the web version of this email update is available here. If you would like to receive these updates via email, please subscribe .
Charlotte Tillett
Gustaf Duhs